Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Lambrecht

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2013
Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicitySandra Nuyts, Maarten Lambrecht, Fréderic Duprez, et al.
Annals of Surgical Oncology|February 25, 2011
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter studyDoenja M J Lambregts, Vincent Vandecaveye, Brunella Barbaro, et al.
Radiation Oncology (London, England)|July 19, 2018
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissueKobe Reynders, Els Wauters, Matthieu Moisse, et al.
Technical Innovations & Patient Support in Radiation Oncology|October 28, 2025
Three-year insights from a proton therapy centre: Evolving strategies in ependymoma treatment planningLieselotte Lauwens, Anneleen Goedgebeur, Tom Boterberg, et al.
The Lancet Regional Health. Europe|July 24, 2024
Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013-2019): a nationwide registry-based prospective studyYolande Lievens, Sharon Janssens, Maarten Lambrecht, et al.
Cancers|December 24, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory StudyRianne D W Vaes, Kobe Reynders, Jenny Sprooten, et al.
Physics in Medicine and Biology|May 6, 2026
Design, development and characterization of pregnant anthropomorphic phantoms for fetal dose measurements in proton therapyMarijke De Saint-Hubert, Jana Hohmann, Werner Schoonjans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2024
Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trialSaskia A Cooke, José S A Belderbos, Bart Reymen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 29, 2025
Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost TrialSaskia A Cooke, José S A Belderbos, Barbara Stam, et al.
Neuro-Oncology|May 4, 2025
Radiotherapy-Induced Neurocognitive Decline among Adult Intracranial Tumor Patients: A Voxel-Based approachCharlotte Sleurs, Catharina M L Zegers, Marvin F Ribeiro, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2013
Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicitySandra Nuyts, Maarten Lambrecht, Fréderic Duprez, et al.
Annals of Surgical Oncology|February 25, 2011
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter studyDoenja M J Lambregts, Vincent Vandecaveye, Brunella Barbaro, et al.
Radiation Oncology (London, England)|July 19, 2018
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissueKobe Reynders, Els Wauters, Matthieu Moisse, et al.
Technical Innovations & Patient Support in Radiation Oncology|October 28, 2025
Three-year insights from a proton therapy centre: Evolving strategies in ependymoma treatment planningLieselotte Lauwens, Anneleen Goedgebeur, Tom Boterberg, et al.
The Lancet Regional Health. Europe|July 24, 2024
Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013-2019): a nationwide registry-based prospective studyYolande Lievens, Sharon Janssens, Maarten Lambrecht, et al.
Cancers|December 24, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory StudyRianne D W Vaes, Kobe Reynders, Jenny Sprooten, et al.
Physics in Medicine and Biology|May 6, 2026
Design, development and characterization of pregnant anthropomorphic phantoms for fetal dose measurements in proton therapyMarijke De Saint-Hubert, Jana Hohmann, Werner Schoonjans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2024
Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trialSaskia A Cooke, José S A Belderbos, Bart Reymen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 29, 2025
Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost TrialSaskia A Cooke, José S A Belderbos, Barbara Stam, et al.
Neuro-Oncology|May 4, 2025
Radiotherapy-Induced Neurocognitive Decline among Adult Intracranial Tumor Patients: A Voxel-Based approachCharlotte Sleurs, Catharina M L Zegers, Marvin F Ribeiro, et al.
Pageof 11